UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020080
Receipt No. R000023191
Official scientific title of the study Research on test battery to evaluate subjective and objective hearing of hearing aid users
Date of disclosure of the study information 2016/01/04
Last modified on 2017/12/06 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Research on test battery to evaluate subjective and objective hearing of hearing aid users
Title of the study (Brief title) Test battery for hearing aid users
Region
Japan

Condition
Condition hearing loss
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Perform subjective and objective hearing test on hearing aid users and to determine the appropriate test battery to evaluate hearing aids.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes CI2004 Japanese speech recognition test score.
Key secondary outcomes Pure tone audiogram, monosyllable recognition test under hearing aid, Speech, Spatial and Qualities of Hearing scale (SSQ) results.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Evaluate Japanese speech recognition ability of hearing aid users using a test (CI2004) designed for cochlear implant users.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Able to understand and decide.
2. Native Japanese speaker.
3. Bilateral hearing loss with >= 45dB hearing threshold in 3-frequency average in both ears.
4. Maximum speech recognition >= 50% at least in one ear.
5. Speech recognition at 50dB <= 50% at least in one ear.
6. Provide written informed consent.
Key exclusion criteria 1. Poor overall health that makes 3 sets of extensive hearing tests invasive.
2. Hearing loss due to bilateral acoustic neuroma.
3. Hearing loss due to intracranial surgery.
4. Hearing loss due to cranial trauma.
5. Scheduled chemotherapy that includes ototoxic anticancer drugs during the research period.
6. Other medical condition that a doctor decides inappropriate to include in the study.
Target sample size 20

Research contact person
Name of lead principal investigator Torahiko Nakashima
Organization Kyushu University Hospital
Division name Department of Otorhinolaryngology
Address 3-1-1 Maidashi Higashi-ku Fukuoka
TEL 81-92-642-5668
Email nakatora@med.kyushu-u.ac.jp

Public contact
Name of contact person Nozomu Matsumoto
Organization Kyushu University Hospital
Division name Department of Otorhinolaryngology
Address 3-1-1 Maidashi Higashi-ku Fukuoka
TEL 81-92-642-5668
Homepage URL
Email matunozo@med.kyushu-u.ac.jp

Sponsor
Institute Kyushu University Hospital
Institute
Department

Funding Source
Organization Oticon Japan
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Oticon Japan
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 01 Month 04 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 01 Month 04 Day
Anticipated trial start date
2016 Year 02 Month 04 Day
Last follow-up date
2016 Year 12 Month 31 Day
Date of closure to data entry
2017 Year 03 Month 31 Day
Date trial data considered complete
2017 Year 03 Month 31 Day
Date analysis concluded
2017 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results https://www.ncbi.nlm.nih.gov/pubmed/29157624
Results
Other related information

Management information
Registered date
2015 Year 12 Month 05 Day
Last modified on
2017 Year 12 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023191